HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

besonprodil

CI-1041 is also known as PD19680; NMDA receptor antagonist for treatment of Parkinson's disease; structure in first source
Also Known As:
6-((2-(4-((4-fluorophenyl)methyl)-1-piperidinyl)ethyl)sulfinyl)-2-(3H)-benzoxazolone; CI-1041; PD 196860; PD196860
Networked: 9 relevant articles (1 outcomes, 2 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Morissette, Marc: 5 articles (04/2010 - 01/2006)
2. Di Paolo, Thérèse: 5 articles (04/2010 - 01/2006)
3. Hadj Tahar, Abdallah: 4 articles (04/2010 - 03/2004)
4. Samadi, Pershia: 3 articles (04/2010 - 06/2009)
5. Grégoire, Laurent: 3 articles (01/2010 - 03/2004)
6. Meltzer, Leonard T: 3 articles (06/2009 - 01/2006)
7. Dridi, Mehdi: 3 articles (06/2009 - 01/2006)
8. Bédard, Paul J: 3 articles (09/2006 - 03/2004)
9. Bélanger, Nancy: 2 articles (04/2010 - 03/2004)
10. Ouattara, Bazoumana: 2 articles (01/2010 - 06/2009)

Related Diseases

1. Seizures (Seizure)
2. Dyskinesias (Dyskinesia)
3. Parkinson Disease (Parkinson's Disease)
4. Hyperalgesia

Related Drugs and Biologics

1. 1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)
2. N-Methylaspartate (NMDA)
3. conotoxin GV
4. preproenkephalin
5. Levodopa (L Dopa)
6. N-Methyl-D-Aspartate Receptors (NMDA Receptors)
7. Benserazide
8. Ro 61-8048
9. cabergoline
10. Kynurenine 3-Monooxygenase (Kynurenine 3 Monooxygenase)

Related Therapies and Procedures

1. Oral Administration